Tag: closing

MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and distributor of pharmaceutical and nutraceutical products, whereby the Purchaser will acquire all the issued and outstanding common shares of the Company for US$3.01 per share in cash plus one contingent value right (“CVR”) per share for additional aggregate cash payments of up to US$1.19 per CVR if certain milestones as described below are achieved (the “Transaction”). The total Transaction consideration, assuming full payment of the CVRs, is US$254 million.

VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- Commodities & Resources PTE Ltd. (the “Acquiror"), a private investment company incorporated in Singapore, announces that on April 8, 2025, the Acquiror acquired Common Shares of Belmont Resources Inc. (TSX-V: BEA)(the “Issuer”). The Issuer completed a private placement of Common Shares, issuing a total of 4,000,000 shares to the Acquiror at a price of $0.045 per share for proceeds of $180,000 (the “Private Placement”).

MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that it will proceed with a best efforts non-brokered private placement offering of units of the Company (the “Units”) to raise maximum gross proceeds of $1,000,000 (the “Unit Offering”).

WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2025, the company granted non-qualified stock options to purchase 10,700 shares of its common stock to two new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan.

Dubai, July 2, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON”), announces today that it has completed the pricing of a private placement of USD 200 million of senior unsecured notes due in 2029 with institutional investors (the “Notes”), following its announcement on June 16, 2025 that it is considering options to raise external financing through a private placement.

ATHENS, Greece, July 02, 2025 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ: PSHG) (“Performance Shipping” or the “Company”) announced today that it has successfully placed USD 100 million of bonds in the Nordic bond market. An application will be made for the bonds to be listed on the Oslo Stock Exchange. The new bonds are due to mature in July 2029 and will pay a fixed coupon of 9.875% per annum, payable semi-annually in arrears and were priced at 97% of par. The bonds are secured in part by first priority mortgages over the Company’s two oldest tanker vessels, which are presently unencumbered. The offering is expected to close on July 17, 2025, subject to customary closing conditions.